Frontiers in bioengineering and biotechnology · 2025
Applications of bone regenerative medicine in the foot and ankle: mechanisms, technologies, and therapeutic advances.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Lianbo, Li Yijie, Wang Tianqi, Zhao Zhuo, Li Wang, Lv Jinghang, Chen Haoran, Qi Zhaodong, Wang Xinming, Bao Wenchi, Liang Haidong
Аннотация
BACKGROUND: Foot and ankle diseases significantly impact quality of life, with regenerative medicine emerging as a promising approach. A comprehensive evaluation of both efficacy and safety is paramount for its clinical translation.
METHODS: A comprehensive literature search was conducted in PubMed using keywords "regenerative medicine" and "foot and ankle" (as of 31 December 2024). Studies were categorized by technology and disease.
RESULTS: PRP and HA showed short-term efficacy in talar cartilage repair; stem cells enhanced functional recovery in ankle osteoarthritis. 3D printing enabled personalized implants. Exosomes and AI were identified as future directions. However, the reporting of safety data was often sporadic and non-standardized, highlighting the need for more systematic monitoring in future studies.
CONCLUSION: Regenerative therapies demonstrate potential but require further validation through robust trials that prioritize standardized safety reporting alongside efficacy outcomes. Gaps in exosome isolation, long-term safety, and clinical translation need addressing.
METHODS: A comprehensive literature search was conducted in PubMed using keywords "regenerative medicine" and "foot and ankle" (as of 31 December 2024). Studies were categorized by technology and disease.
RESULTS: PRP and HA showed short-term efficacy in talar cartilage repair; stem cells enhanced functional recovery in ankle osteoarthritis. 3D printing enabled personalized implants. Exosomes and AI were identified as future directions. However, the reporting of safety data was often sporadic and non-standardized, highlighting the need for more systematic monitoring in future studies.
CONCLUSION: Regenerative therapies demonstrate potential but require further validation through robust trials that prioritize standardized safety reporting alongside efficacy outcomes. Gaps in exosome isolation, long-term safety, and clinical translation need addressing.